BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2003696)

  • 1. PAF antagonism as an approach to the treatment of airway hyperreactivity.
    Meade CJ; Heuer H
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children.
    Hsieh KH
    Chest; 1991 Apr; 99(4):877-82. PubMed ID: 2009789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma.
    Hozawa S; Haruta Y; Ishioka S; Yamakido M
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1198-202. PubMed ID: 7551370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.
    Havill AM; Van Valen RG; Handley DA
    Br J Pharmacol; 1990 Feb; 99(2):396-400. PubMed ID: 2328403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA; Magnusson JE; Wurtman RJ
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PAF receptor antagonist in asthma therapy].
    Sagara H; Makino S; Fukuda T
    Nihon Rinsho; 1996 Nov; 54(11):3056-61. PubMed ID: 8950954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats.
    Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB
    J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs.
    Sakuma Y; Tsunoda H; Shirato M; Katayama S; Yamatsu I; Katayama K
    Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for platelet-activating factor in asthma.
    Chung KF; Barnes PJ
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterolobin induces rat paw oedema independently of PAF-acether.
    Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W; Chao W; Levine BA; Olson MS
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible role for PAF in allergen-induced late responses: modification by a selective antagonist.
    Abraham WM; Stevenson JS; Garrido R
    J Appl Physiol (1985); 1989 May; 66(5):2351-7. PubMed ID: 2745300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat.
    Zhou W; McCollum MO; Levine BA; Olson MS
    Am J Pathol; 1992 Apr; 140(4):971-9. PubMed ID: 1562055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
    Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.